<Page>
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
CANTEL MEDICAL CORP.
----------------------
(Exact name of registrant as specified in its charter)
DELAWARE 22-1260285
- ------------------------------------- -----------------------------------------
(State of incorporation) IRS Employer Identification No.)
or organization)
150 CLOVE ROAD, LITTLE FALLS, NEW JERSEY 07424
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
<Table>
<Caption>
Title of each class Name of each exchange on which
to be so registered each class is to be registered
Common Stock, par value $.10 New York Stock Exchange
</Table>
Securities to be registered pursuant to Section 12(g) of the Act:
NONE
<Page>
Item 1: DESCRIPTION OF REGISTRANTS SECURITIES
TO BE REGISTERED
-------------------------------------
COMMON STOCK, PAR VALUE $.10
The Capital Stock of Cantel Medical Corp. (the "Company") to
be registered on the New York Stock Exchange, Inc. (the "Exchange") is the
Company's Common Stock, par value $.10 per share ("Common Stock"). Holders of
Common Stock are entitled to one vote per share at all meetings of stockholders.
Dividends that may be declared on the Common stock will be paid in an equal
amount to the holder of each share. No pre-emptive rights are conferred upon the
holders of such Stock and there are no liquidation or conversion rights. There
are no redemption or sinking fund provisions and there is no liability to
further calls or to assessments by the Company.
Item 2: EXHIBITS
1. All exhibits required by Instruction II to Items 2 will be filed
with the Exchange.
2
<Page>
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 21, 2002
CANTEL MEDICAL CORP.
By: /s/ James P. Reilly
---------------------------
James P. Reilly, President
and Chief Executive Officer
3